Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024177
Filing Date
2020-05-11
Accepted
2020-05-11 16:08:21
Documents
67
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-10q_20200331.htm   iXBRL 10-Q 2577197
2 EX-31.1 enta-ex311_7.htm EX-31.1 16196
3 EX-31.2 enta-ex312_8.htm EX-31.2 16182
4 EX-32.1 enta-ex321_6.htm EX-32.1 8920
5 GRAPHIC gket0l3pgzn2000001.jpg GRAPHIC 38975
  Complete submission text file 0001564590-20-024177.txt   8868517

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20200331.xsd EX-101.SCH 39664
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20200331_cal.xml EX-101.CAL 60198
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20200331_def.xml EX-101.DEF 108904
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20200331_lab.xml EX-101.LAB 351133
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20200331_pre.xml EX-101.PRE 281455
62 EXTRACTED XBRL INSTANCE DOCUMENT enta-10q_20200331_htm.xml XML 1950625
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 20864827
SIC: 2834 Pharmaceutical Preparations